Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Industry Insights

Healthesystems' clinicians, data analysts, compliance officers, and business leaders are at the forefront of the issues and events that affect the workers’ compensation and healthcare industries.
Drawing on their expertise and insights, Healthesystems produces and publishes a variety of educational resources that help workers' compensation professionals stay informed and gain a deeper understanding of:
New drugs and other pharmacological updates
Medical equipment and service developments
Population demographics
Regulatory and policy news
Business, industry, and cultural trends

RxInformer

Award-winning journal providing in-depth analysis on today’s most important topics

State of the States

Sandy Shtab, Healthesystems AVP of Advocacy and Compliance, comments on regulatory activity across the country.
Winter 2021/2022

Stepping Up to Take on Pandemic Ripple Effects

A message from the Chief Executive Officer
Winter 2021/2022

Ask a Clinician: What Is the Difference Between Physical and Occupational Therapies?

Healthe's clinicians tackle common workers' comp questions
Winter 2021/2022

Workers' Comprehensive

Monthly e-newsletter covering news stories relevant to workers’ compensation

2024 Workers’ Comp Industry Insights Survey Report

This sixth annual survey report highlights the top challenges and priorities of 500 industry professionals.
Feb 2024

U.S. Department of Labor Issues Final Rule on Worker Classification

The rule clarifies differences between employees and contractors, establishing who is entitled to benefits – including workers’ comp.
Feb 2024

Ten Psychedelic Bills Introduced Across State Legislatures

States so far include Alaska, Arizona, California, Hawaii, Indiana, Illinois, Massachusetts, Maryland, New Jersey, and Wisconsin.
Feb 2024

Clinical Guidance

“Clinical Minute” videos and other helpful resources from our clinical experts

Could Convalescent Plasma Treat COVID-19?

The FDA, JAMA, and others think blood from those who recovered from COVID-19 could benefit those with the illness.
Apr 2020

FDA Addresses Manufacturing Disruptions

Will disruptions in manufacturing result in drug shortages?
Mar 2020

NSAID Use and COVID-19

FDA investigates claims that NSAID use could aggravate COVID-19 symptoms.
Mar 2020
1 13 14 15 16 17 25

Whitepapers

lockenvelopephone-handsetmagnifiermenucross-circle